0.22Open0.10Pre Close1 Volume256 Open Interest76.00Strike Price22.00Turnover124.10%IV2.48%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type-0.2076Delta0.1542Gamma353.23Leverage Ratio-1.9674Theta-0.0001Rho-73.34Eff Leverage0.0043Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet